Literature DB >> 23855697

Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach.

Marilyn K Glassberg, Joshua M Hare, Rebecca L Toonkel, Michael A Matthay.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23855697      PMCID： PMC3778759          DOI： 10.1164/rccm.201302-0244LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

1.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Authors:  Ganesh Raghu; Kevin J Anstrom; Talmadge E King; Joseph A Lasky; Fernando J Martinez
Journal:  N Engl J Med       Date:  2012-05-20       Impact factor: 91.245

2.  Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

Authors:  Henry C Quevedo; Konstantinos E Hatzistergos; Behzad N Oskouei; Gary S Feigenbaum; Jose E Rodriguez; David Valdes; Pradip M Pattany; Juan P Zambrano; Qinghua Hu; Ian McNiece; Alan W Heldman; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-05       Impact factor: 11.205

3.  The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

Authors:  J Gao; J E Dennis; R F Muzic; M Lundberg; A I Caplan
Journal:  Cells Tissues Organs       Date:  2001       Impact factor: 2.481

Review 4.  Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect.

Authors:  Argyris Tzouvelekis; Geoff Laurent; Demosthenes Bouros
Journal:  Curr Drug Targets       Date:  2013-02       Impact factor: 3.465

5.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

6.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Authors:  Joshua M Hare; Joel E Fishman; Gary Gerstenblith; Darcy L DiFede Velazquez; Juan P Zambrano; Viky Y Suncion; Melissa Tracy; Eduard Ghersin; Peter V Johnston; Jeffrey A Brinker; Elayne Breton; Janice Davis-Sproul; Ivonne H Schulman; John Byrnes; Adam M Mendizabal; Maureen H Lowery; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Phillip Ruiz; Alexandra Amador; Jose Da Silva; Ian K McNiece; Alan W Heldman; Richard George; Albert Lardo
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

Review 7.  Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.

Authors:  Rebecca L Toonkel; Joshua M Hare; Michael A Matthay; Marilyn K Glassberg
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

8.  Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal.

Authors:  Argyris Tzouvelekis; George Koliakos; Paschalis Ntolios; Irene Baira; Evangelos Bouros; Anastasia Oikonomou; Athanassios Zissimopoulos; George Kolios; Despoina Kakagia; Vassilis Paspaliaris; Ioannis Kotsianidis; Marios Froudarakis; Demosthenes Bouros
Journal:  J Transl Med       Date:  2011-10-21       Impact factor: 5.531

9.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779
  9 in total
  2 in total

1.  Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis.

Authors:  Marcelo M Morales; Sérgio A L Souza; Luiz Paulo Loivos; Marina A Lima; Amir Szklo; Leandro Vairo; Taís H K Brunswick; Bianca Gutfilen; Miquéias Lopes-Pacheco; Alberto J Araújo; Alexandre P Cardoso; Regina C Goldenberg; Patricia R M Rocco; Lea M B Fonseca; José R Lapa e Silva
Journal:  BMC Pulm Med       Date:  2015-06-11       Impact factor: 3.317

Review 2.  Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.

Authors:  Argyrios Tzouvelekis; Rebecca Toonkel; Theodoros Karampitsakos; Kantha Medapalli; Ioanna Ninou; Vasilis Aidinis; Demosthenes Bouros; Marilyn K Glassberg
Journal:  Front Med (Lausanne)       Date:  2018-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.